ASCO 2021: The science behind olaparib’s promise shown in the OlympiA early breast cancer trial 04 Jun 2021 The OlympiA trial results show the benefits of a targeted drug in patients with early-stage breast cancer and inherited BRCA mutations. We spoke to Chair of the OlympiA steering committee Professor Andrew Tutt about the landmark ICR research that underpins this major breakthrough. Find out more Show/Hide
Mother’s Day: The generations of mums inspiring their children to become scientists 12 Mar 2021 Molly Andrews spoke to four of our scientists about the pivotal roles their mothers played in inspiring them to pursue careers in science, some of the barriers mothers face, and the importance of continuing to strive for gender equality in science. Find out more Show/Hide
Gynaecological Cancer Awareness Month: New trial offers hope for patients with rare hard-to-treat gynaecological cancer 30 Sep 2020 Around 21,000 people are diagnosed with a gynaecological cancer in the UK each year. This September - Gynaecological Cancer Awareness Month - our Communications Administrator Molly Andrews spoke to Professor Chris Lord and Dr Susana Banerjee about an important new trial in the gynaecological cancer field. Find out more Show/Hide
“Here you really can make a difference” – Professor Chris Lord reflects on the biggest developments in his career so far 18 Oct 2018